Innovative Jawbone Organoids from Patient-Derived iPS Cells Advance Bone Disease Research and Treatments

A groundbreaking study from Kyoto University introduces jawbone-like organoids derived from patient iPS cells, enabling advanced research into bone diseases and regenerative therapies, including models for osteogenesis imperfecta.
Researchers at Kyoto University have developed a pioneering method to create jawbone-like organoids from human induced pluripotent stem (iPS) cells. These mini-organs mimic the development and structure of the human jawbone, offering a new model to study bone diseases and potential therapies. The team, led by Associate Professor Makoto Ikeya, successfully optimized conditions to differentiate iPS cells into cranial neural crest cells (NCCs), which are critical for jawbone formation. They then induced these NCCs to develop into mandibular prominence ectomesenchyme (mdEM), an intermediate tissue resembling embryonic jaw tissue.
Using this model, the scientists cultured the mdEMs under osteo-inductive conditions, resulting in mineralized tissue clusters that demonstrate bone formation characteristics. They further transplanted these jawbone organoids into mice, where they matured into vascularized, mineralized bone tissue, confirming their potential for regenerative applications.
To explore disease modeling, the team used iPS cells from a patient with osteogenesis imperfecta (OI), a genetic disorder causing brittle bones. The organoids derived from these OI patient cells showed abnormal collagen secretion and reduced expression of osteogenic markers, mimicking disease features. Conversely, genetically corrected organoids displayed improved bone matrix formation, highlighting the potential for personalized therapeutic studies.
The research points toward the future use of these jawbone organoids for understanding developmental processes, disease mechanisms, and testing regenerative therapies. This breakthrough provides a valuable platform for advancing jawbone-related research, especially for genetic disorders like OI.
This study was published in Nature Biomedical Engineering and marks a significant step forward in bone tissue engineering and disease modeling.
For more details, see the original publication: Souta Motoike et al, Jawbone-like organoids generated from human pluripotent stem cells, Nature Biomedical Engineering (2025). DOI: 10.1038/s41551-025-01419-3. Source: https://medicalxpress.com/news/2025-07-jawbone-organoids-patient-ips-cells.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Genetic Target Offers Hope for Liver Cancer Treatment
Discover how groundbreaking research identifying the gene TAF2 offers new potential for targeted liver cancer therapies, aiming to improve patient outcomes and advance treatment options.
Innovative Dual Action Immunotherapy Enhances CAR-T Cell Treatment for B-ALL
A novel dual-targeting CAR-T cell therapy shows promise in controlling B-cell acute lymphoblastic leukemia and reducing relapse by addressing immune escape mechanisms.